Alnylam Pharmaceuticals, Inc.
Nasdaq 100
$248.68
+0.47%
Delayed · cached 15 min
Frequently asked questions
What sector does Alnylam Pharmaceuticals, Inc. belong to?
Alnylam Pharmaceuticals, Inc. operates in the Healthcare sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of ALNY?
As of the latest available quote, ALNY traded at $248.68. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of ALNY?
Alnylam Pharmaceuticals, Inc. has a price-to-earnings (P/E) ratio of about 43.32. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of ALNY?
The market capitalisation of Alnylam Pharmaceuticals, Inc. is approximately $33.49B.
Is Alnylam Pharmaceuticals, Inc. profitable?
For its latest reported financial year, Alnylam Pharmaceuticals, Inc. recorded a net profit margin of about 8.45%.
Does ALNY pay a dividend?
Alnylam Pharmaceuticals, Inc. does not currently show a dividend yield in our data.
What is the return on equity (ROE) of ALNY?
Alnylam Pharmaceuticals, Inc. has a return on equity (ROE) of about 23.17%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of ALNY?
Over the past 52 weeks, ALNY has traded between a low of $197.81 and a high of $495.55.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.